Antiviral Properties of 5-Sulfamoyl-1H-Indole-Linked Spirothiazolidinone Derivatives: A Study on Human Parainfluenza Virus-2
dc.authorid | Akdemir, Atilla/0000-0001-8416-0471 | |
dc.authorid | Trawally, Muhammed/0000-0002-0041-4612 | |
dc.authorwosid | Akdemir, Atilla/G-2595-2015 | |
dc.contributor.author | Trawally, Muhammed | |
dc.contributor.author | Yilmaz, Fatima Nur | |
dc.contributor.author | Ozbek Celik, Berna | |
dc.contributor.author | Akdemir, Atilla | |
dc.contributor.author | Guzel Akdemir, Ozlen | |
dc.date.accessioned | 2024-05-19T14:46:09Z | |
dc.date.available | 2024-05-19T14:46:09Z | |
dc.date.issued | 2024 | |
dc.department | İstinye Üniversitesi | en_US |
dc.description.abstract | Human parainfluenza viruses (HPIVs) are responsible for a wide range of respiratory infections in humans, particularly in children, the elderly, and immunocompromised individuals. This paper presents a study regarding the antiviral activity of a series of 3-phenyl-5-sulfamoyl-N-(7/8/9-(non)substituted-3-oxo-1-thia-4- azaspiro[4.4]non/[4.5]dec-4-yl)-1H-indole-2-carboxamide derivatives against HPIV-2. Our findings suggest the compounds displayed low potency against HPIV-2. Compounds 4 and 8 exhibited the most potent antiviral effects with inhibition of 95.46 and 90.90 % at 10 mg/mL, respectively. Molecular modeling studies were conducted on hemagglutinin-neuraminidase, a crucial druggable target for HPIV, to predict the binding modes of the compounds. | en_US |
dc.description.sponsorship | Istanbul University Scientific Research Projects [T-15108] | en_US |
dc.description.sponsorship | This research was funded by Istanbul University Scientific Research Projects under project Number: T-15108. | en_US |
dc.identifier.doi | 10.29228/jrp.689 | |
dc.identifier.endpage | 224 | en_US |
dc.identifier.issn | 2630-6344 | |
dc.identifier.issue | 1 | en_US |
dc.identifier.scopus | 2-s2.0-85185505017 | en_US |
dc.identifier.scopusquality | Q3 | en_US |
dc.identifier.startpage | 213 | en_US |
dc.identifier.uri | https://doi.org10.29228/jrp.689 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12713/5456 | |
dc.identifier.volume | 28 | en_US |
dc.identifier.wos | WOS:001167297700013 | en_US |
dc.identifier.wosquality | N/A | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.language.iso | en | en_US |
dc.publisher | Marmara Univ | en_US |
dc.relation.ispartof | Journal of Research In Pharmacy | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.snmz | 20240519_ka | en_US |
dc.subject | Parainfluenza Virus | en_US |
dc.subject | Hpiv-2 | en_US |
dc.subject | Indole | en_US |
dc.subject | Thiazolidinone | en_US |
dc.subject | Hemagglutinin-Neuraminidase | en_US |
dc.subject | Molecular Docking | en_US |
dc.title | Antiviral Properties of 5-Sulfamoyl-1H-Indole-Linked Spirothiazolidinone Derivatives: A Study on Human Parainfluenza Virus-2 | en_US |
dc.type | Article | en_US |